AtheroTalk with Noam Zelcer
Noam shares his perspectives on the evolving field of lipid metabolism research. Besides his scientific insights, he encourages us to discuss our failures, which are “a feature of science, not a bug”. Another key message: “Define clear go/no-go milestones for your project”.
If you are interested in his work, he currently has an open position for a PhD student as also discussed during this episode.
Script-prep: Pelin Golforoush and Emiel van der Vorst
Interviewer: Emiel van der Vorst
https://podcasts.apple.com/nl/podcast/e13-noam-zelcer/id1780340626?i=1000708428204
Share this message
Latest news Medical Biochemistry Amsterdam
Project MERCURY is taking off! Prof Noam Zelcer has been awarded an NWO open competition grant to study hepatic APOB metabolism and VLDL production. To do so, innovative proteomic and genetic approaches coupled to in vivo studies will be used to understand how APOB/VLDL is lipidated, trafficked, and secreted in hepatocytes.
At the annual Dutch Atherosclerosis Society (DAS) meeting, Lobke received the award for Best Flash Talk for her presentation on the role of LXR in macrophage immune activation, while Ricky was awarded Best Poster Presentation for his work on the role of IRF1 in macrophage function. Congratulations to both!
